MSLAb - An open-source masked stereolithography (mSLA) bioprinter.

ABSTRACT: 3D bioprinting is a tissue engineering approach using additive manufacturing to fabricate tissue equivalents for regenerative medicine or medical drug testing. For this purpose, biomaterials that provide the essential microenvironment to support the viability of cells integrated directly or seeded after printing are processed into three-dimensional (3D) structures. Compared to extrusion-based 3D printing, which is most commonly used in bioprinting, stereolithography (SLA) offers a higher printing resolution and faster processing speeds with a wide range of cell-friendly materials such as gelatin- or collagen-based hydrogels and SLA is, therefore, well suited to generate 3D tissue constructs. While there have been numerous publications of conversions and upgrades for extrusion-based printer

SUBMITTER: Kaufmann BK 

PROVIDER: S-EPMC11234000 | biostudies-literature | 2024 Sep

REPOSITORIES: biostudies-literature